Mai C, Fukui A, Saeki S, Takeyama R, Yamaya A, Shibahara H
Reprod Med Biol. 2025; 24(1):e12610.
PMID: 39807425
PMC: 11725765.
DOI: 10.1002/rmb2.12610.
Lee H, Ko D, Heo H, Baek S, Kim E, Kwon E
PLoS One. 2025; 20(1):e0315981.
PMID: 39752457
PMC: 11698320.
DOI: 10.1371/journal.pone.0315981.
Mariuzza R, Singh P, Karade S, Shahid S, Sharma V
Immunol Rev. 2025; 329(1):e13435.
PMID: 39748148
PMC: 11695704.
DOI: 10.1111/imr.13435.
Lee S, Kim J, Jang I, Jo S, Lee S, Oh S
Int J Mol Sci. 2024; 25(19).
PMID: 39408655
PMC: 11476788.
DOI: 10.3390/ijms251910326.
Coenon L, Geindreau M, Ghiringhelli F, Villalba M, Bruchard M
Cell Death Dis. 2024; 15(8):614.
PMID: 39179536
PMC: 11343846.
DOI: 10.1038/s41419-024-06976-0.
Human NK cells and cancer.
Cantoni C, Falco M, Vitale M, Pietra G, Munari E, Pende D
Oncoimmunology. 2024; 13(1):2378520.
PMID: 39022338
PMC: 11253890.
DOI: 10.1080/2162402X.2024.2378520.
BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells.
Alashkar Alhamwe B, Ponath V, Alhamdan F, Dorsam B, Landwehr C, Linder M
Cell Mol Immunol. 2024; 21(8):918-931.
PMID: 38942797
PMC: 11291976.
DOI: 10.1038/s41423-024-01195-1.
Natural killer cells in cancer immunotherapy.
Wang D, Dou L, Sui L, Xue Y, Xu S
MedComm (2020). 2024; 5(7):e626.
PMID: 38882209
PMC: 11179524.
DOI: 10.1002/mco2.626.
Killer instincts: natural killer cells as multifactorial cancer immunotherapy.
Nersesian S, Carter E, Lee S, Westhaver L, Boudreau J
Front Immunol. 2023; 14:1269614.
PMID: 38090565
PMC: 10715270.
DOI: 10.3389/fimmu.2023.1269614.
Deficiency of N-linked glycosylation impairs immune function of B7-H6.
Chen H, Zhang Y, Shen Y, Jiang L, Zhang G, Zhang X
Front Immunol. 2023; 14:1255667.
PMID: 38035117
PMC: 10684670.
DOI: 10.3389/fimmu.2023.1255667.
SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses.
Molfetta R, Petillo S, Cippitelli M, Paolini R
Front Cell Dev Biol. 2023; 11:1213114.
PMID: 37313439
PMC: 10258607.
DOI: 10.3389/fcell.2023.1213114.
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T.
Liu Q, Li J, Zheng H, Yang S, Hua Y, Huang N
Mol Cancer. 2023; 22(1):28.
PMID: 36750830
PMC: 9903509.
DOI: 10.1186/s12943-023-01735-9.
Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure.
Lai Z, Wang Y, Zhou W, Liang Z, Shi J, Yang H
Theranostics. 2022; 12(15):6527-6547.
PMID: 36185612
PMC: 9516226.
DOI: 10.7150/thno.74053.
Innate lymphoid cells in early tumor development.
Warner K, Ghaedi M, Chung D, Jacquelot N, Ohashi P
Front Immunol. 2022; 13:948358.
PMID: 36032129
PMC: 9411809.
DOI: 10.3389/fimmu.2022.948358.
NK Cell-Based Immunotherapy in Colorectal Cancer.
Della Chiesa M, Setti C, Giordano C, Obino V, Greppi M, Pesce S
Vaccines (Basel). 2022; 10(7).
PMID: 35891197
PMC: 9323201.
DOI: 10.3390/vaccines10071033.
What Inhibits Natural Killers' Performance in Tumour.
Papak I, Chrusciel E, Dziubek K, Kurkowiak M, Urban-Wojciuk Z, Marjanski T
Int J Mol Sci. 2022; 23(13).
PMID: 35806034
PMC: 9266640.
DOI: 10.3390/ijms23137030.
Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer.
Medjouel Khlifi H, Guia S, Vivier E, Narni-Mancinelli E
Front Immunol. 2022; 13:898745.
PMID: 35757695
PMC: 9231431.
DOI: 10.3389/fimmu.2022.898745.
The emerging role of γδ T cells in cancer immunotherapy.
Nussbaumer O, Koslowski M
Immunooncol Technol. 2022; 1:3-10.
PMID: 35755322
PMC: 9216673.
DOI: 10.1016/j.iotech.2019.06.002.
DNA methylation biomarkers in asthma and rhinitis: Are we there yet?.
Legaki E, Arsenis C, Taka S, Papadopoulos N
Clin Transl Allergy. 2022; 12(3):e12131.
PMID: 35344303
PMC: 8967268.
DOI: 10.1002/clt2.12131.
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer.
Peipp M, Klausz K, Boje A, Zeller T, Zielonka S, Kellner C
Clin Exp Immunol. 2022; 209(1):22-32.
PMID: 35325068
PMC: 9307233.
DOI: 10.1093/cei/uxac028.